Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Enzalutamide
by Highest Patent Value in the world in 2021

The Enzalutamide top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Enzalutamide Key Players in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Enzalutamide is used to treat men with a certain type of prostate cancer.
#
Company Name
Region
Tech Topics
Total
1
Cambridgeshire, United Kingdom
Medicine,Health care,Side effect,
...[+2]
Avg patent value: 6.50 M
2
Cambridgeshire, United Kingdom
Avg patent value: 6.50 M
3
Avg patent value: 5.98 M
4
Tokyo, Japan
Avg patent value: 3.70 M
5
Ljubljana, Slovenia
Avg patent value: 2.29 M
6
Avg patent value: 1.76 M
7
Avg patent value: 1.19 M
8
Avg patent value: 660,000
9
Avg patent value: 261,000
10
Medicine,Health care,Pharmacy and Therapeutics,
...[+2]
Avg patent value: 252,410
11
Lombardia, Italy
Avg patent value: 210,000
12
Avg patent value: 190,000
13
Avg patent value: 180,000
14
Avg patent value: 150,000
15
Avg patent value: 85,000
16
Rheinland-Pfalz, Germany
Avg patent value: 78,000
17
Avg patent value: 66,000
18
Jerusalem, Israel
Health care,Technology transfer,Biomedicine,
...[+2]
Avg patent value: 60,000
19
Medicine,Health care,Therapeutic protein,
...[+2]
Avg patent value: 48,000
20
Czechia
Avg patent value: 43,433
Page generation time: Jun 05 2025